CIBRA Capital Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$51.9M |
| 2 |
DESP
Despegar.com
DESP
|
+$25.7M |
| 3 |
BERY
Berry Global Group, Inc.
BERY
|
+$22.4M |
| 4 |
AMED
Amedisys
AMED
|
+$15.6M |
| 5 |
SPR
Spirit AeroSystems
SPR
|
+$11.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SMAR
Smartsheet Inc.
SMAR
|
+$24M |
| 2 |
MTTR
Matterport, Inc. Class A Common Stock
MTTR
|
+$4.69M |
| 3 |
ALTM
Arcadium Lithium plc
ALTM
|
+$4.23M |
| 4 |
RVNC
Revance Therapeutics, Inc.
RVNC
|
+$3.47M |
| 5 |
SLB Ltd
SLB
|
+$3.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 32.94% |
| 2 | Consumer Staples | 12.67% |
| 3 | Consumer Discretionary | 10.69% |
| 4 | Materials | 10.16% |
| 5 | Energy | 9.48% |
Similar funds
CIBRA Capital's Q1 2025 Portfolio in Review
As of Q1 2025, CIBRA Capital held 38 positions worth $293M, up 99% from $147M the previous quarter. Its ten largest holdings account for 85% of the portfolio.
CIBRA Capital deployed $135M of net new capital in Q1 2025, opening 14 new positions and adding to 6 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.
By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 5.9% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.
On the sell side, the largest reduction was Discover Financial Services, an estimated $2.08M trimmed.
- CIBRA Capital's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 416,218 shares worth $54.9M.
- CIBRA Capital added most to Berry Global Group, Inc. in Q1 2025, an estimated $22.4M increase.
- CIBRA Capital's biggest Q1 2025 reduction was Discover Financial Services, cutting an estimated $2.08M.
- CIBRA Capital fully exited Smartsheet Inc. in Q1 2025, selling an estimated $24M.
- CIBRA Capital's ten largest holdings make up 85% of its $293M portfolio in Q1 2025.
- CIBRA Capital opened 14 new positions and closed 13 in Q1 2025.
- CIBRA Capital's portfolio value rose 99% quarter-over-quarter to $293M.
Based on CIBRA Capital's 13F filing for Q1 2025, filed 28 Apr 2025.